1-3 of 3
Ichiro Yasuda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Objective Response and Progression-Free Survival Contribute to Prolong Overall Survival in Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma

Available to Purchase
Subject Area:
Oncology
Kazuto Tajiri, Kenichiro Tsukada, Yoshiharu Tokimitsu, Yuchi Motofuji, Kengo Kawai, Nozomu Muraishi, Aiko Murayama, Yuka Hayashi, Yukihiro Shimizu, Ichiro Yasuda
Journal: Oncology
Oncology (2024) 102 (2): 131–140.
https://doi.org/10.1159/000533952
Published Online: 04 September 2023
View articletitled, Objective Response and Progression-Free Survival Contribute to Prolong Overall Survival in Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma
Open the PDF for Objective Response and Progression-Free Survival Contribute to Prolong Overall Survival in Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma in another window
Journal Articles

Factors, Including Clinical Trial Eligibility, Associated with Induction of Third-Line Treatment for Advanced Gastric Cancer

Available to Purchase
Subject Area:
Karger e-Journal Backfile Collection 2023 , Oncology
Takayuki Ando, Ayumu Hosokawa, Miho Sakumura, Iori Motoo, Shinya Kajiura, Katsuhisa Hirano, Takeshi Miwa, Tomotaka Yokota, Naokatsu Nakada, Yuko Ueda, Akira Ueda, Kenichiro Tsukada, Kohei Ogawa, Atsuko Nakaya, Akira Teramoto, Sohachi Nanjo, Hiroshi Mihara, Haruka Fujinami, Tsutomu Fujii, Ichiro Yasuda
Journal: Oncology
Oncology (2023) 101 (1): 59–68.
https://doi.org/10.1159/000526577
Published Online: 24 January 2023
View articletitled, Factors, Including Clinical Trial Eligibility, Associated with Induction of Third-Line Treatment for Advanced Gastric Cancer
Open the PDF for Factors, Including Clinical Trial Eligibility, Associated with Induction of Third-Line Treatment for Advanced Gastric Cancer in another window
Journal Articles

The Impact of Lenvatinib on Tumor Blood Vessel Shrinkage of Hepatocellular Carcinoma during Treatment: An Imaging-Based Analysis

Open Access
Subject Area:
Karger e-Journal Backfile Collection 2023 , Oncology
Nozomu Muraishi, Yusuke Kawamura, Norio Akuta, Junichi Shindoh, Masaru Matsumura, Satoshi Okubo, Shunichiro Fujiyama, Tetsuya Hosaka, Satoshi Saitoh, Hitomi Sezaki, Fumitaka Suzuki, Yoshiyuki Suzuki, Kenji Ikeda, Yasuji Arase, Masaji Hashimoto, Ichiro Yasuda, Hiromitsu Kumada
Journal: Oncology
Oncology (2023) 101 (2): 134–144.
https://doi.org/10.1159/000526976
Published Online: 14 September 2022
View articletitled, The Impact of Lenvatinib on Tumor Blood Vessel Shrinkage of Hepatocellular Carcinoma during Treatment: An Imaging-Based Analysis
Open the PDF for The Impact of Lenvatinib on Tumor Blood Vessel Shrinkage of Hepatocellular Carcinoma during Treatment: An Imaging-Based Analysis in another window